Thursday, October 21, 2021

Padma Shri honored Tamil actor Vivek dies, succumbed to hospital after chest pain

Mumbai. Vivek, a well-known Tamil industry star, has said goodbye to the world at 4:35 am. The actor died in a hospital in Chennai, giving fans and the Tamil industry a never ending shock. He had complained of chest pain a day earlier i.e. on Friday. After which he was admitted to the hospital. Vivek died during treatment. This information is given in the medical bulletin issued by the hospital.

On Friday, 59-year-old Tamil actor Vivek was admitted to a hospital in Chennai in an unconscious state. It is being told that Comedian Vivek had vaccinated Kovid 19 on Thursday. The news came last day that 100 percent blockage has occurred in one of the actor’s heart veins, due to which he suffered a heart attack and his condition worsened.

According to the doctors treating Vivek, he was put on extracorporeal membrane oxygenation (ECMO). Which allows blood to flow from an artificial lung to the blood vessels. ECMO works from outside the body of the patient, like the lungs and lungs. However, Vivek’s condition did not improve after all this and he died on Saturday at 4:35 am. At the same time, the doctors also say that Vivek’s condition and his death have nothing to do with the corona vaccination.

Read Also:  Review: Elizabeth Strout writes a 'Lucy Barton' sequel

Tamil actor Vivek Padmashri has been honored with the award. He worked with many big actors. Which includes many big Tamil superstars including Rajinikanth, Vijay and Ajit Kumar. Vivek has acted in more than 500 films till now. Bollywood’s famous singer and music composer AR Rahman has also mourned the actor’s death. AR Rahman has described Vivek’s death as a major setback for the industry.

.

Nation World News Deskhttps://nationworldnews.com
Nation World News is the fastest emerging news website covering all the latest news, world’s top stories, science news entertainment sports cricket’s latest discoveries, new technology gadgets, politics news, and more.
Latest news
Related news
- Advertisement -